Sustained and cancer cell targeted cytosolic delivery of Onconase results in potent antitumor effectsHONG LIANG ZHAO; CHONG XUE; JI LIANG DU et al.Journal of controlled release. 2012, Vol 159, Num 3, pp 346-352, issn 0168-3659, 7 p.Article

Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitorMIKULSKI, S. M; VIERA, A; DEPTALA, A et al.International journal of oncology. 1998, Vol 13, Num 4, pp 633-644, issn 1019-6439Article

Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stressARDELT, B; JUAN, G; ARDELT, W et al.International journal of oncology. 2007, Vol 31, Num 3, pp 663-669, issn 1019-6439, 7 p.Article

RNA damage and inhibition of neoplastic endothelial cell growth : Effects of human and amphibian ribonucleasesNEWTON, Dianne L; KAUR, Gurmeet; RHIM, Johng S et al.Radiation research. 2001, Vol 155, Num 1, pp 171-174, issn 0033-7587, 2Conference Paper

Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamilyVASANDANI, V. M; WU, Y.-N; MIKULSKI, S. M et al.Cancer research (Baltimore). 1996, Vol 56, Num 18, pp 4180-4186, issn 0008-5472Article

Ribonucleases as potential modalities in anticancer therapyARDELT, Wojciech; ARDELT, Barbara; DARZYNKIEWICZ, Zbigniew et al.European journal of pharmacology. 2009, Vol 625, Num 1-3, pp 181-189, issn 0014-2999, 9 p.Article

Combined effects of onconase and IFN-β on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cellsTSAI, S. Y; HSIEH, T. C; ARDELT, B et al.International journal of oncology. 2002, Vol 20, Num 5, pp 891-896, issn 1019-6439Article

Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptakeVASANDANI, V. M; BURRIS, J. A; SUNG, C et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 2, pp 164-169, issn 0344-5704Article

Potentiation of tumor necrosis factor induced apoptosis by onconaseDEPTALA, A; HALICKA, H. D; ARDELT, B et al.International journal of oncology. 1998, Vol 13, Num 1, pp 11-16, issn 1019-6439Article

Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancerLEE, Intae; SHOGEN, Kuslima.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 337-346, issn 0344-5704, 10 p.Article

Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-κBTSAR, Shwu Y; ARDELT, Barbara; HSIEH, Tze-Chen et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1745-1752, issn 1019-6439, 8 p.Article

Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude miceLEE, Intae; KALOTA, Anna; GEWIRTZ, Alan M et al.Anticancer research. 2007, Vol 27, Num 1A, pp 299-307, issn 0250-7005, 9 p.Article